546 related articles for article (PubMed ID: 17331130)
1. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning.
Kalpoe JS; van der Heiden PL; Barge RM; Houtzager S; Lankester AC; van Tol MJ; Kroes AC
Eur J Haematol; 2007 Apr; 78(4):314-21. PubMed ID: 17331130
[TBL] [Abstract][Full Text] [Related]
2. Quantification of adenovirus DNA in unrelated donor hematopoietic stem cell transplant recipients.
Gustafson I; Lindblom A; Yun Z; Omar H; Engstrom L; Lewensohn-Fuchs I; Ljungman P; Broliden K
J Clin Virol; 2008 Sep; 43(1):79-85. PubMed ID: 18550426
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral infection in hematopoietic stem cell transplantation: early diagnosis with quantitative detection of the viral genome in serum and urine.
Teramura T; Naya M; Yoshihara T; Kanoh G; Morimoto A; Imashuku S
Bone Marrow Transplant; 2004 Jan; 33(1):87-92. PubMed ID: 14578929
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients.
Satwani P; Baldinger L; Freedman J; Jacobson JS; Guerra J; van de Ven C; Morris E; Garvin J; George D; Bradley MB; Bhatia M; Tallamy B; Schwartz J; Jin Z; Cairo MS
Biol Blood Marrow Transplant; 2009 Dec; 15(12):1587-95. PubMed ID: 19896083
[TBL] [Abstract][Full Text] [Related]
5. Incidence and treatment strategy for disseminated adenovirus disease after haploidentical stem cell transplantation.
Taniguchi K; Yoshihara S; Tamaki H; Fujimoto T; Ikegame K; Kaida K; Nakata J; Inoue T; Kato R; Fujioka T; Okada M; Soma T; Ogawa H
Ann Hematol; 2012 Aug; 91(8):1305-12. PubMed ID: 22476883
[TBL] [Abstract][Full Text] [Related]
6. Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level.
Ivanov V; Faucher C; Mohty M; Bilger K; Ladaique P; Sainty D; Arnoulet C; Chabannon C; Vey N; Camerlo J; Bouabdallah R; Maraninchi D; Bardou VJ; Blaise D
Transfusion; 2004 Apr; 44(4):501-8. PubMed ID: 15043564
[TBL] [Abstract][Full Text] [Related]
7. Comparable incidence and severity of cytomegalovirus infections following T cell-depleted allogeneic stem cell transplantation preceded by reduced intensity or myeloablative conditioning.
Kalpoe JS; van der Heiden PL; Vaessen N; Claas EC; Barge RM; Kroes AC
Bone Marrow Transplant; 2007 Jul; 40(2):137-43. PubMed ID: 17530007
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of quantitative PCR for adenovirus detection in stool samples as compared with antigen detection and cell culture in haematopoietic stem cell transplant recipients.
Jeulin H; Salmon A; Bordigoni P; Venard V
Clin Microbiol Infect; 2011 Nov; 17(11):1674-80. PubMed ID: 21481083
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of quantitative varicella-zoster virus (VZV) DNA detection in plasma after stem cell transplantation.
Kalpoe JS; Kroes AC; Verkerk S; Claas EC; Barge RM; Beersma MF
Bone Marrow Transplant; 2006 Jul; 38(1):41-6. PubMed ID: 16715108
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study.
Runde V; Ross S; Trenschel R; Lagemann E; Basu O; Renzing-Köhler K; Schaefer UW; Roggendorf M; Holler E
Bone Marrow Transplant; 2001 Jul; 28(1):51-7. PubMed ID: 11498744
[TBL] [Abstract][Full Text] [Related]
11. Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation.
Myers GD; Bollard CM; Wu MF; Weiss H; Rooney CM; Heslop HE; Leen AM
Bone Marrow Transplant; 2007 Jun; 39(11):677-86. PubMed ID: 17417664
[TBL] [Abstract][Full Text] [Related]
12. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.
Neofytos D; Ojha A; Mookerjee B; Wagner J; Filicko J; Ferber A; Dessain S; Grosso D; Brunner J; Flomenberg N; Flomenberg P
Biol Blood Marrow Transplant; 2007 Jan; 13(1):74-81. PubMed ID: 17222755
[TBL] [Abstract][Full Text] [Related]
13. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation.
Kampmann B; Cubitt D; Walls T; Naik P; Depala M; Samarasinghe S; Robson D; Hassan A; Rao K; Gaspar H; Davies G; Jones A; Cale C; Gilmour K; Real M; Foo M; Bennett-Rees N; Hewitt A; Amrolia P; Veys P
Br J Haematol; 2005 Aug; 130(4):595-603. PubMed ID: 16098075
[TBL] [Abstract][Full Text] [Related]
14. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K
Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054
[TBL] [Abstract][Full Text] [Related]
15. High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation.
Schilham MW; Claas EC; van Zaane W; Heemskerk B; Vossen JM; Lankester AC; Toes RE; Echavarria M; Kroes AC; van Tol MJ
Clin Infect Dis; 2002 Sep; 35(5):526-32. PubMed ID: 12173125
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantation.
Seidel MG; Fritsch G; Matthes-Martin S; Lawitschka A; Lion T; Pötschger U; Rosenmayr A; Fischer G; Gadner H; Peters C
Haematologica; 2005 Oct; 90(10):1405-14. PubMed ID: 16219578
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome.
Öhrmalm L; Lindblom A; Omar H; Norbeck O; Gustafson I; Lewensohn-Fuchs I; Johansson JE; Brune M; Ljungman P; Broliden K
Bone Marrow Transplant; 2011 Feb; 46(2):267-72. PubMed ID: 20400984
[TBL] [Abstract][Full Text] [Related]
18. High lethality of human adenovirus disease in adult allogeneic stem cell transplant recipients with high adenoviral blood load.
Ganzenmueller T; Buchholz S; Harste G; Dammann E; Trenschel R; Heim A
J Clin Virol; 2011 Sep; 52(1):55-9. PubMed ID: 21742548
[TBL] [Abstract][Full Text] [Related]
19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
Transplantation; 2009 Nov; 88(10):1222-6. PubMed ID: 19935377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
